Company intelligence / Profile preview

Pisgah Labs

Pisgah Forest, North Carolina, United States6sense.com ↗

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Pisgah Labs has developed patented technologies for abuse-deterrent formulations of opioids/narcotics at the API level. It holds 31 patents and manufactures APIs used in approved drugs for pain, Alzheimer’s disease, and fibromyalgia. Its P2P Interventions platform is designed to make recreational drug use more difficult without compromising efficacy. Clinical results from combination hydrocodone/APAP product were anticipated as of 2013; current status not publicly updated.

Therapeutic areas: PsychiatryRheumatologyNeurology
Modalities: Small moleculeAbuse deterrent technology
Industry: Biotech

Beyond the preview

Go deeper on Pisgah Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pisgah Labs.

Explore the full profile